Stocks and Investing Stocks and Investing
Tue, July 14, 2020
Mon, July 13, 2020

Jason Gerberry Maintained (BLUE) at Strong Buy with Decreased Target to $100 on, Jul 13th, 2020


Published on 2024-10-27 09:30:34 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $104 to $100 on, Jul 13th, 2020.

Jason has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $73 on, Thursday, May 28th, 2020


These are the ratings of the 3 analyists that currently disagree with Jason


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $133 on, Friday, June 12th, 2020
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $112 on, Tuesday, May 12th, 2020
  • Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Decreased Target to $70 on, Friday, March 27th, 2020

Contributing Sources